Immunotherapy: Open Access
Open Access

A Comprehensive Pan-Cancer Analysis of Obg-like ATPase 1 (OLA1): A Prognostic and Immunological Biomarker

Jian-Kun Zhang, Lu-Yang Zou, Yi-Yi Cai, Yue Liu, Xin-Yu Chen, Yi-Wen Wu, Dong Xu3,

Cytokine Release Syndrome in Oncolytic Approaches: Reducing Side Effects

Jack Stephen*

DOI: 10.35248/2471-9552.24.10.271

Advancements in Intratumoral Immunotherapy: A Targeted Approach to Tumor Treatment

Margie Degiuseppe*

DOI: 10.35248/2471-9552.24.10.270

Resolving Blood-Brain Barrier: Advancing Immunotherapy for Cerebral Cancer Treatment

Bristen Hardy*

DOI: 10.35248/2471-9552.24.10.269

Immunologic Strategies Transforming Hematologic Cancer Care: A Creative Approach

Victor Kim*

DOI: 10.35248/2471-9552.24.10.268

Cancer Vaccines: Transforming the Field of Prophylactic Immunotherapy

Andrew Doey*

DOI: 10.35248/2471-9552.24.10.267

Transforming Oncology Care: The Role of Natural Killer Cells in Modern Treatment

Medina Olmedo*

DOI: 10.35248/2471-9552.24.10.266

Advancing Tumor Mutational Burden: Enhancing Cancer Treatment Strategies with Genetic Profiling

Kerry Hannah*

DOI: 10.35248/2471-9552.24.10.264